Actinium amends at-the-market sales agreement, adds B. Riley Securities as agent

Actinium Pharmaceuticals, Inc.

Original Capital on Demand Sales Agreement (Aug 2020) allowed up to $200M in ATM offerings via JonesTrading.
A&R Sales Agreement dated June 28, 2022 adds B. Riley Securities as an additional sales agent.
No other material changes to terms; remaining $200M capacity unaffected.
Agreement filed as Exhibit 1.1; representations are for parties only, not factual disclosures.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.